Sanofi (NASDAQ:SNY) Q4 2024 Earnings Call Transcript ... submit your question by clicking the Q&A icon at the bottom of the screen. Your question will be read, by our panelists.

The Sanofi Global Health Unit plays an important ... submit your question by clicking the Q&A icon at the bottom of the screen. Your question will be read, by our panelists. Now, we'll take ...

Fortunately, we are making some progress as organizations such as the Partnership for Advancing Clinical Trials (PACT) ...

Q4 2024 Earnings Conference Call February 7, 2025 3:00 AM ETCompany ParticipantsNicolas Hieronimus - CEOChristophe Babule ...

Sanofi and CD&R sign Opella share purchase agreementParis, February 19, 2025. Following completion of the required social and corporate ...

The FDA granted orphan designation to Sanofi ( SNY) US Services’ rilzabrutinib as a treatment of autoimmune hemolytic anemia, according to a post to the agency’s website. Published first on TheFly – ...

J&J, Sanofi Stop E.coli Vaccine Trial Due to Low Effectiveness (Reuters) - Johnson & Johnson and partner Sanofi will stop a late-stage trial of an experimental vaccine to prevent infections caused ...

On an adjusted basis, Biogen expects 2025 profit between $15.25 and $16.25 per share. It earned $16.47 in 2024 and analysts ...

Nielsen, 28, was diagnosed with MS aged 17 and initially believed that her athletics dreams were over due to her lack of ...

Sanofi has removed (PDF) a clutch of programs from its clinical pipeline, scratching out entries for its late-phase BTK inhibitor and phase 1 prospects linked to the multibillion-dollar takeovers ...